Crossref
journal-article
Elsevier BV
Neuromuscular Disorders (78)
References
38
Referenced
44
10.1016/0092-8674(92)90154-5
/ Cell / Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member by Brook (1992)10.1093/hmg/ddl181
/ Hum Mol Genet / RNA-dominant diseases by Osborne (2006)10.1073/pnas.94.14.7388
/ Proc Natl Acad Sci USA / Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts by Davis (1997)10.1083/jcb.128.6.995
/ J Cell Biol / Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues by Taneja (1995)10.1093/emboj/19.17.4439
/ EMBO J / Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy by Miller (2000)10.1093/hmg/ddl132
/ Hum Mol Genet / Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy by Lin (2006)10.1126/science.280.5364.737
/ Science / Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy by Philips (1998)10.1126/science.1088583
/ Science / A muscleblind knockout model for myotonic dystrophy by Kanadia (2003)10.1016/S1097-2765(02)00563-4
/ Mol Cell / Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy by Mankodi (2002)10.1016/S1097-2765(02)00572-5
/ Mol Cell / Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing by Charlet (2002)10.1212/01.WNL.0000148482.40683.88
/ Neurology / Truncated ClC-1 mRNA in myotonic dystrophy exerts a dominant-negative effect on the Cl current by Berg (2004)10.1073/pnas.0604970103
/ Proc Natl Acad Sci USA / Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy by Kanadia (2006)10.1016/S0896-6273(01)00353-1
/ Neuron / Targeting transcription to the neuromuscular synapse by Schaeffer (2001)10.1002/bies.10205
/ Bioessays / Localizing synaptic mRNAs at the neuromuscular junction: it takes more than transcription by Chakkalakal (2003)10.1016/j.conb.2005.12.003
/ Curr Opin Neurobiol / Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost by Kummer (2006)10.1093/hmg/2.11.1889
/ Hum Mol Genet / Myotonic dystrophy kinase is a component of neuromuscular junctions by van der Ven (1993)10.1093/hmg/4.6.1063
/ Hum Mol Genet / Characterization of myotonic dystrophy kinase (DMK) protein in human and rodent muscle and central nervous tissue by Whiting (1995)10.1038/ng0796-325
/ Nat Genet / Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy by Reddy (1996)10.1093/hmg/7.12.1957
/ Hum Mol Genet / Localization of myotonic dystrophy protein kinase in human and rabbit tissues using a new panel of monoclonal antibodies by Pham (1998)10.1126/science.289.5485.1769
/ Science / Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat by Mankodi (2000)10.1038/ng0796-316
/ Nat Genet / Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice by Jansen (1996)10.1093/hmg/ddh327
/ Hum Mol Genet / Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons by Jiang (2004)10.1038/sj.emboj.7600300
/ EMBO J / Muscleblind proteins regulate alternative splicing by Ho (2004)10.1038/ncb1335
/ Nat Cell Biol / RNA-dependent integrin alpha3 protein localization regulated by the muscleblind-like protein MLP1 by Adereth (2005)10.1093/hmg/10.19.2143
/ Hum Mol Genet / Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1 by Sergeant (2001)10.1212/WNL.47.3.711
/ Neurology / Specific tau variants in the brains of patients with myotonic dystrophy by Vermersch (1996)10.1007/s004010051148
/ Acta Neuropathol / Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein by Probst (2000)10.1001/archneur.1976.00500010035006
/ Arch Neurol / Peripheral nerve morphometry in myotonic dystrophy by Pollock (1976)10.1016/S0021-9258(18)54211-3
/ J Biol Chem / Quantitative analysis of the human alpha-skeletal actin gene in transgenic mice by Brennan (1993)10.1093/brain/84.1.75
/ Brain / The histology of the neuromuscular junction in dystrophia myotonica by MacDermot (1961){'issue': 'Pt 1', 'key': '10.1016/j.nmd.2006.12.015_bib31', 'first-page': '1', 'article-title': 'The intramuscular nerve endings in dystrophia myotonica–a biopsy study by vital staining and electron microscopy', 'volume': '105', 'author': 'Allen', 'year': '1969', 'journal-title': 'J Anat'}
/ J Anat / The intramuscular nerve endings in dystrophia myotonica–a biopsy study by vital staining and electron microscopy by Allen (1969)10.1001/archneur.1973.00490280027003
/ Arch Neurol / Terminal innervation ratio in neuromuscular disease. II. Disorders of lower motor neuron, peripheral nerve, and muscle by Coers (1973)- Fardeau M, Tome FMS. Light and electron microscopic study of motor endplates in the adult and neo-natal forms of dystrophia myotonica. In: Taxi J, ed. Ontogenesis and Functional Mechanisms of Peripheral Synapses: Proceedings of the INSERM Symposium on Ontogenesis and Functional Mechanisms of Peripheral Synapses. Amsterdam: Elsevier/North-Holland Biomedical Press, 1980: 287–98.
- Engel AG, Jerusalem F, Tsujihata M, Gomez MR. The neuromuscular junction in myopathies: a quantitative ultrastructural study. In: Bradley WG, Gardner-Medwin D, Walton JN, eds. Recent Advances in Myology: Proceedings of the Third International Congress on Muscle Diseases, International Congress Series no. 360. New York: Elsevier, 1975: 132–43.
10.1001/archneur.1976.00500070027005
/ Arch Neurol / Are muscle fibers denervated in myotonic dystrophy? by Drachman (1976)10.1111/j.1460-9568.2004.03783.x
/ Eur J Neurosci / Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington’s disease mutation by Ribchester (2004)10.1016/S0021-9258(18)47032-9
/ J Biol Chem / Role of innervation, excitability, and myogenic factors in the expression of the muscular chloride channel ClC-1. A study on normal and myotonic muscle by Klocke (1994)10.1523/JNEUROSCI.3252-04.2005
/ J Neurosci / Activity-dependent presynaptic regulation of quantal size at the mammalian neuromuscular junction in vivo by Wang (2005)
Dates
Type | When |
---|---|
Created | 18 years, 6 months ago (Feb. 16, 2007, 7:23 a.m.) |
Deposited | 4 years ago (Aug. 8, 2021, 4:54 p.m.) |
Indexed | 4 months, 1 week ago (April 22, 2025, 3:14 a.m.) |
Issued | 18 years, 6 months ago (March 1, 2007) |
Published | 18 years, 6 months ago (March 1, 2007) |
Published Print | 18 years, 6 months ago (March 1, 2007) |
@article{Wheeler_2007, title={Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1}, volume={17}, ISSN={0960-8966}, url={http://dx.doi.org/10.1016/j.nmd.2006.12.015}, DOI={10.1016/j.nmd.2006.12.015}, number={3}, journal={Neuromuscular Disorders}, publisher={Elsevier BV}, author={Wheeler, T.M. and Krym, M.C. and Thornton, C.A.}, year={2007}, month=mar, pages={242–247} }